Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Defining the brain circuits involved in psychiatric disorders: IMI-NEWMEDS

Abstract

Despite the vast amount of research on schizophrenia and depression in the past two decades, there have been few innovative drugs to treat these disorders. Precompetitive research collaborations between companies and academic groups can help tackle this innovation deficit, as illustrated by the achievements of the IMI-NEWMEDS consortium.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Godsil, B. P. et al. The hippocampal−prefrontal pathway: the weak link in psychiatric disorders? Eur. Neuropsychopharmacol. 23, 1165–1181 (2013).

    Article  CAS  Google Scholar 

  2. Troyano-Rodríguez, E. et al. Phencyclidine inhibits the activity of thalamic reticular gamma-aminobutyric acidergic neurons in rat brain. Biol. Psychiatry 76, 937–945 (2014).

    Article  Google Scholar 

  3. Santana, N. et al. Activation of thalamocortical networks by the N-methyl-d-aspartate receptor antagonist phencyclidine: reversal by clozapine. Biol. Psychiatry 69, 918–927 (2011).

    Article  CAS  Google Scholar 

  4. Lladó-Pelfort, L. et al. Phencyclidine-induced disruption of oscillatory activity in prefrontal cortex: effects of antipsychotic drugs and receptor ligands. Eur. Neuropsychopharmacol. 26, 614–625 (2016).

    Article  Google Scholar 

  5. Grimm, O. et al. Acute ketamine challenge increases resting state prefrontal–hippocampal connectivity in both humans and rats. Psychopharmacology 232, 4231–4241 (2015).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Francesc Artigas or Michael Spedding.

Ethics declarations

Competing interests

Some of the authors are employed in the pharmaceutical industry, as indicated in the address list.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Artigas, F., Schenker, E., Celada, P. et al. Defining the brain circuits involved in psychiatric disorders: IMI-NEWMEDS. Nat Rev Drug Discov 16, 1–2 (2017). https://doi.org/10.1038/nrd.2016.205

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2016.205

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research